WCAMG
GILD icon

Woodard & Company Asset Management Group’s Gilead Sciences GILD Stock Holding History

Woodard & Company Asset Management Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-130
Closed -$8K – 97
2018
Q3 		$8K Hold
130
– – 0.01% 168
2018
Q2 		$9.21K Hold
130
– – 0.01% 149
2018
Q1 		$8K Hold
130
– – 0.01% 157
2017
Q4 		$8K Buy
+130
New +$9.87K 0.01% 174

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Woodard & Company Asset Management Group's GILD Position: Q4 2018 in Review

Woodard & Company Asset Management Group sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 130 shares — an estimated $8K sold.

Woodard & Company Asset Management Group first reported a position in GILD in Q4 2017 and held it in 4 quarters. The position peaked at $9.21K in Q2 2018. 1,497 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Woodard & Company Asset Management Group reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Woodard & Company Asset Management Group sold 130 Gilead Sciences shares in Q4 2018, an estimated $8K.
  • Woodard & Company Asset Management Group first reported a position in Gilead Sciences in Q4 2017 and held it in 4 quarters.
  • Woodard & Company Asset Management Group's Gilead Sciences position peaked at $9.21K in Q2 2018.
  • 1,497 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Woodard & Company Asset Management Group's 13F filing for Q4 2018, filed 1 Feb 2019.